 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor |
| Youjin Chang, Seon Ye Kim, Yun Jung Choi, Kwang Sup So, Jin Kyung Rho, Woo Sung Kim, Jae Cheol Lee, Jin-Haeng Chung, Chang-Min Choi |
|
Tuberc Respir Dis. 2013;75(3):95-103. Published online September 30, 2013 DOI: https://doi.org/10.4046/trd.2013.75.3.95 |
|
Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Tuberculosis and Respiratory Diseases. 2013;75(3):95  Does the Addition of Vascular Endothelial Growth Factor Inhibitors to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Overcome T790M Acquired Resistance? Journal of Thoracic Oncology. 2011;6(2):404 Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor Open Life Sciences. 2016;11(1):427-431 Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway Clinical Lung Cancer. 2009;10(4):281-289 Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer Cancers. 2022;14(3):686 Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance Therapeutic Advances in Respiratory Disease. 2015;9(5):242-250 Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor Respirology Case Reports. 2016;5(1):e00206 The addition of apatinib to gefitinib or icotinib for advanced non-small cell lung cancer with acquired resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitor: An assessment of effectiveness and safety Annals of Oncology. 2017;28:v483 Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma Tuberculosis and Respiratory Diseases. 2016;79(4):248 Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 Seminars in Oncology. 2001;28:56-66 |
